LianBio inks $325M IPO for pipeline with BMS, BridgeBio, Lyra
01 Nov 2021 //
FIERCEBIOTECH
BridgeBio grabs a second priority review for the portfolio — giving Perceptive
02 Dec 2020 //
ENDPTS
BridgeBio Pharma & Affiliate QED Announce FDA Acceptance NDA for Infigratinib
01 Dec 2020 //
GLOBENEWSWIRE
Ivy Brain Tumor Center and BridgeBio Pharma’s QED Announce Dosing
28 Jul 2020 //
GLOBENEWSWIRE